Johnson & Johnson to Buy Halda Therapeutics For $3.05 Billion

wsj.com/business/deals/johnson-johnson-to-buy-halda-therapeutics-for-3-05-billion-2e460ca1

Johnson & Johnson has agreed to buy clinical-stage biotechnology company Halda Therapeutics for $3.05 billion in cash in a deal that bolsters the healthcare giant’s oncology pipeline.

This story appeared on wsj.com, 2025-11-17 13:29:00.
The Entire Business World on a Single Page. Free to Use →